Back to Agenda
How to Provide Necessary Medicinal Products to Children?
Session Chair(s)
Junko Sato, PhD
Associate Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
In this session, speakers share the efficacy of exsiting pediatric regulation and discuss future collaboration to promote pediatric drug development worldwide
Learning Objective : Describe the pediatric regulation of Japan, US and engagement of emerging counties; Discuss collaboration to promote pediatric drug development in these countries.
Speaker(s)
PMDA Update
Michiyo Sakiyama, MD
Associate Senior Scientist for Clinical Medicine, Office of Vaccines and Blood, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
FDA Update
Gerold Wharton
Program Analyst, Office of Clinical Policy and Programs, OC, FDA, United States
How to Provide Necessary Medicinal Products to Children - An Industry Perspective
Robert "Skip" Nelson, MD, PhD
Executive Director, Pediatric Drug Development (CHILD), Johnson & Johnson, United States
Have an account?